ASG News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

AS

Mkt Cap

$315.7M

Volume

368.88K

Loading chart

AS

ASGLIBERTY ALL-STAR GROWTH FD

ASG

Pay with—

Available Balance0.00

AS

AUM

$316.0M

Volume

368.88K

Yield

9.68%

Chart Earnings News About Dividends Insider Filings

Aurora Spine Corporation Announces First Quarter 2024 Financial ResultsNOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICESGlobeNewswire Inc. · May 14, 2024

Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fiscal Year 2024 Financial ResultsCARLSBAD, Calif. , May 13, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has scheduled a conference call to update investors and discuss its first quarter fiscal 2024 financial results that ended March 31, 2024. Management will host the conference call on Tuesday May 14, 2024 at 11:00 a.m. Eastern Time.GlobeNewswire Inc. · May 13, 2024

Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2023 Financial ResultsNOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICESGlobeNewswire Inc. · Apr 30, 2024

Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion DeviceCARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants announced today that it has completed the second full year of implantation of the world’s first patient-bone-density matched interbody device, the cervical interbody DEXA-C.GlobeNewswire Inc. · Mar 20, 2024

Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent OfficeCARLSBAD, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its second United States Patent No: 11,850,162 entitled “Body Density Scan Result-Matched Orthopedic Implants and Methods of Use” for The World’s First DEXA Technology™ Patient-Matched Implant Technology.GlobeNewswire Inc. · Feb 5, 2024

The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating TubeCARLSBAD, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 11,832,853 entitled “Hybrid Radiolucent Surgical Operating Tube”.GlobeNewswire Inc. · Jan 29, 2024

AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETINGCARLSBAD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the North American Neuromodulation Society (“NANS”) Annual Meeting from January 18-21 in Las Vegas, Nevada. The NANS Annual Meeting is a prominent medical conference that brings together healthcare professionals, researchers, and experts in the field of neuromodulation.GlobeNewswire Inc. · Jan 18, 2024

Aurora Spine Announces Attendance at J.P. Morgan Healthcare ConferenceCARLSBAD, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be attending the J.P. Morgan Healthcare Conference in San Francisco, CA the week of January 8-11, 2024. The conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. The company’s President and CEO, Trent Northcutt, will be presenting the Aurora story to several financial institutions and individuals.GlobeNewswire Inc. · Jan 8, 2024

Aurora Spine Corporation Announces Newly Published Paper on First 6-month Clinical Evaluation of its ZIP™ Fusion ImplantCARLSBAD, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the publication of the first 6-month clinical evaluation of its ZIP™ fusion implant in the Journal of Pain Research.GlobeNewswire Inc. · Dec 4, 2023

Aurora Spine Grants Stock OptionsCarlsbad, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announces that it has granted options (the "Options") to acquire 1,000,000 common shares of the Company to Trent J. Northcutt, President & CEO. The Options are exercisable at a price of CDN$0.395 per common share and vest one third on the first, second and third annual anniversaries from the date of grant. The Options have a term of five years and are subject in all respects to the terms of the Company's stock option plan.GlobeNewswire Inc. · Nov 17, 2023

to start trading

AS

ASGLIBERTY ALL-STAR GROWTH FD

ASG

Pay with—

Available Balance0.00

Your PositionYou don't own any ASG yet.

Related Tickers

Earnings

Dividends

Last · Jul 16Quarterly

Amount$0.12

Yield9.48%

Annual$0.47